[Pre-, per- and post-allogeneic haematopoietic stem cell transplant rehabilitation (Atelier SFGM-TC)].

Virgile Pinelli, Laure Christophe, Nathalie Cheron, Sarah Morin, Lila Gilis, Candy Heuze, Dominique Clerc-Renaud, Laurence Morotti, Benoit Vilhet, Sandra Bissardon, Leonardo Magro
{"title":"[Pre-, per- and post-allogeneic haematopoietic stem cell transplant rehabilitation (Atelier SFGM-TC)].","authors":"Virgile Pinelli, Laure Christophe, Nathalie Cheron, Sarah Morin, Lila Gilis, Candy Heuze, Dominique Clerc-Renaud, Laurence Morotti, Benoit Vilhet, Sandra Bissardon, Leonardo Magro","doi":"10.1016/j.bulcan.2024.05.006","DOIUrl":null,"url":null,"abstract":"<p><p>Allogeneic transplantation of haematopoietic stem cells is still the only curative treatment for certain haematological malignancies. This treatment can be responsible for a number of side-effects, leading to multiple and interdependent physical and psychological deficiencies that affect patients' quality of life and social participation, and can be experienced as a handicap, sometimes for several years after the transplant. For several years now, the integration of post-transplant rehabilitation pathways has been becoming more widespread, and initiatives to provide multidisciplinary care at an increasingly early stage are being studied. The aim of this early management is to improve the patient's overall functional state before, during and after the transplant, in order to limit the impact of the treatment and ensure the quickest possible return to a life that is as satisfying as possible. The international literature and the experiments carried out throughout the French-speaking world describe heterogeneous practices. Based on this literature and experience, the aim of this study is to issue homogenous recommendations for good clinical practice and to identify areas for further research into pre-transplant, per-transplant and post-transplant rehabilitation of haematopoietic stem cells.</p>","PeriodicalId":93917,"journal":{"name":"Bulletin du cancer","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bulletin du cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.bulcan.2024.05.006","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Allogeneic transplantation of haematopoietic stem cells is still the only curative treatment for certain haematological malignancies. This treatment can be responsible for a number of side-effects, leading to multiple and interdependent physical and psychological deficiencies that affect patients' quality of life and social participation, and can be experienced as a handicap, sometimes for several years after the transplant. For several years now, the integration of post-transplant rehabilitation pathways has been becoming more widespread, and initiatives to provide multidisciplinary care at an increasingly early stage are being studied. The aim of this early management is to improve the patient's overall functional state before, during and after the transplant, in order to limit the impact of the treatment and ensure the quickest possible return to a life that is as satisfying as possible. The international literature and the experiments carried out throughout the French-speaking world describe heterogeneous practices. Based on this literature and experience, the aim of this study is to issue homogenous recommendations for good clinical practice and to identify areas for further research into pre-transplant, per-transplant and post-transplant rehabilitation of haematopoietic stem cells.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[异体造血干细胞移植前、移植前和移植后的康复(Atelier SFGM-TC)]。
异体造血干细胞移植仍然是治疗某些血液恶性肿瘤的唯一方法。这种治疗方法可能会产生一些副作用,导致多种相互依存的生理和心理缺陷,影响患者的生活质量和社会参与,并可能成为一种障碍,有时会在移植后持续数年。几年来,移植后康复路径的整合已变得越来越普遍,在越来越早的阶段提供多学科护理的举措也在研究之中。这种早期管理的目的是改善患者在移植前、移植期间和移植后的整体功能状态,以限制治疗的影响,确保患者尽快恢复尽可能令人满意的生活。国际文献和在法语国家进行的实验描述了各种不同的做法。根据这些文献和经验,本研究旨在为良好的临床实践提出统一的建议,并确定造血干细胞移植前、移植期间和移植后康复的进一步研究领域。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
[Nivolumab plus chemotherapy in neoadjuvant treatment of NSCLC with PD-L1 expression≥1]. [Capivasertib in combination with fulvestrant in locally advanced or metastatic RH+ HER2- breast cancer with PIK3CA, AKT1 or PTEN alteration, after first-line hormonal therapy]. [Molecular profiling in biliary tract cancers: A national practice survey of French platforms]. [Perioperative pembrolizumab for early-stage non-small-cell lung cancer]. [Development and validation of a tool for the systematic identification of social vulnerabilities in cancer patients: the DEFCO tool].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1